Christensen Group - Applied Organic and Macromolecular Chemistry

The Christensen Group works with organic synthesis and medicinal chemistry involving both small molecules and macromolecules.

Research focus

The group synthesises molecules for applications in drug delivery, microbiology and photodynamic therapy. The work includes both small molecules and macromolecules.

Since some of the group’s products are biologically tested, purity, scalability and batch-to-batch reproducibility are key elements.

The group develops or improves synthetic methods when needed for a specific project.

Group leader

Research


Two examples of ongoing projects are:

Photodynamic Therapy (PDT) for treatment of Aetherosclerosis 
(CosmoPHOS-nano)

Aetherosclerosis (causing cardiac arrest) is the main cause of premature death in Europe and North America. There is no treatment only palliative treatment (bypass, stents, balloon expansion..). In this project, we developed the first nanoparticle capable of targeting the inflammated plaques causing the problems allowing for diagnostics and treatment with photodynamic therapy. Projects in this area could be synthesis of dendrimers or synthesis of new reagents for PDT, which can used treatment of other diseases as well.

New Antibiotics
Resistance towards antibiotics has been growing for a long time and some microbiologists claim that “we are living in the post-antibiotic ages now”, where more and more infections become untreatable. We discovered a couple of years ago a new type of antibiotics in a collaboration with Rikke Heidemann Olsen from Department of Veterinary and Animal Science, KU. We were looking for new bacterial efflux-pump inhibitors but found something else by serendipity. A project in this area would be synthesis of new potentially active compounds, which are subsequently tested for activity. We are especially interested in finding active compounds, that are fluorescent in order to locate the compounds in the bacteria and finding the mode of action.

Projects

Projects in the group are within the following topics:

  • synthesis and testing of new antibiotics
  • design, synthesis and testing of bacterial efflux pump inhibitors
  • guest-host complexes of dendrimers for drug delivery
  • agents for photodynamic therapy
  • sensors for small biomolecules
  • self-assembled nanostructures for applications in nanomedicine

Project work may also involve planning and execution of organic synthesis.

Contact

Jørn Bolstad Christensen
Associate Professor
  • Job responsibility
    Group leader